A Phase III, Randomized, Multicenter, Open-Label, Non-Inferiority Stud
Research payments
$1,186,392
Through program year 2023, $1,186,392 in research payments was reported against A Phase III, Randomized, Multicenter, Open-Label, Non-Inferiority Stud, across 323 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $16,124 | 4 |
| 2022 | Research | $159,213 | 73 |
| 2021 | Research | $302,520 | 87 |
| 2020 | Research | $706,805 | 157 |
| 2019 | Research | $1,730 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ronald Nahass Princeton, NJ Named on 34 payments
- Debbie Hagins Savannah, GA Named on 23 payments
- Olayemi Osiyemi West Palm Beach, FL Named on 19 payments
- Lisa Clough Kansas City, KS Named on 18 payments
- Princy Kumar Washington, DC Named on 18 payments
- Sally Hodder Morgantown, WV Named on 14 payments
- Laura Salazar Newport Beach, CA Named on 13 payments
- La Shonda Spencer Los Angeles, CA Named on 12 payments
- Mitchell Whitehead Pensacola, FL Named on 11 payments
- James Homans Los Angeles, CA Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.